Alkermes
ALKS
#3226
Rank
S$5.81 B
Marketcap
S$34.91
Share price
-1.63%
Change (1 day)
-23.63%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): S$0.53 Billion

According to Alkermes's latest financial reports the company's current earnings are S$1.52 Billion. In 2024 the company made an earning of S$0.59 Billion a decrease over its 2023 earnings that were of S$0.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.53 B-10.67%
2024 S$0.59 B-17.97%
2023 S$0.72 B-468.52%
2022 -S$0.2 Billion449.24%
2021 -S$36.06 Million-68.04%
2020 -S$0.12 Billion-52.1%
2019 -S$0.24 Billion64.49%
2018 -S$0.15 Billion-15.04%
2017 -S$0.17 Billion-34.2%
2016 -S$0.26 Billion-5.34%
2015 -S$0.28 Billion35084.97%
2014 -S$0.77 Million
2012 S$9.52 M-117.81%
2011 -S$53.51 Million-12.69%
2010 -S$61.28 Million94.3%
2009 -S$31.54 Million-117.7%
2008 S$0.17 B622.63%
2007 S$24.65 M
2004 -S$97.52 Million-14.48%
2003 -S$0.12 Billion11.88%
2002 -S$0.11 Billion39.65%
2001 -S$72.99 Million5.73%
2000 -S$69.03 Million-28.91%
1999 -S$97.1 Million237.28%
1998 -S$28.79 Million100.05%
1997 -S$14.39 Million-37.93%
1996 -S$23.19 Million82.72%
1995 -S$12.69 Million-26.79%
1994 -S$17.33 Million-72.78%
1993 -S$63.67 Million208.07%
1992 -S$20.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.58 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.98 B 3,931.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.21 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.68 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$10.31 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.80 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-S$0.28 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-S$0.35 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.76 B 430.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel